Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma

for
Relapsed/Refractory Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06066359

Phase1, Phase2, Recruiting

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

for
Breast Cancer, Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05694559

Recruiting

The Rise in Robotic Atypical Segmentectomies

for
Lung Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04644952

Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma
Location: Houston TX, Aurora CO, Tucson AZ, Columbus OH,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT04565275

Phase1, Phase2, Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia,
Location: Houston TX, Birmingham AL, Nashville TN, Cincinnati OH,
Sponsor: Vincerx Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06034275

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

for
Colonic Neoplasms
Location: Houston TX, Minneapolis MN, Ann Arbor MI,
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT00843375

Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Houston TX, San Antonio TX, Dallas TX, Kansas City MO,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase1, Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: Houston TX, Nashville TN, Iowa City IA, Warrenville IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase2, Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Houston TX, Westwood KS, Iowa City IA, Detroit MI,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase1, Phase2, Recruiting

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

for
Solid Tumors
Location: Houston TX, Gainesville FL, Philadelphia PA
Sponsor: Shionogi

Sex: All

Age: 18+

Code: NCT05101070

Phase1, Phase2, Recruiting

YL-13027 in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Houston TX
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT05228600

Phase1, Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Houston TX, Gainesville FL, Louisville KY, Kissimmee FL,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06352359

Phase1, Recruiting

Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

for
Advanced Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06369259

Phase2, Recruiting

A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer

for
Metastatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06693687

Recruiting

Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)

for
Myelodysplastic Syndrome
Location: Houston TX
Sponsor: Arno Therapeutics

Sex: All

Age: 18+

Code: NCT00956787

Phase2, Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Houston TX, Boston MA
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT06641908

Phase1, Recruiting

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for
Solid Tumors
Location: Houston TX, Austin TX, Minneapolis MN, Grand Rapids MI,
Sponsor: Adcentrx Therapeutics

Sex: All

Age: 18+

Code: NCT06710379

Phase1, Recruiting

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

for
Endometrial Clear Cell Adenocarcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05049538

Recruiting

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia, CLL, Untreated, Front-line,
Location: Houston TX, La Jolla CA, New Hyde Park NY, Boston MA
Sponsor: Chronic Lymphocytic Leukemia Research Consortium

Sex: All

Age: 0+

Code: NCT00628238

Phase2, Recruiting

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

for
Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation
Location: Houston TX, Philadelphia PA, Basking Ridge NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06123338

Phase2, Recruiting